InvestorsHub Logo
Post# of 252498
Next 10
Followers 832
Posts 119983
Boards Moderated 17
Alias Born 09/05/2002

Re: isolution post# 243

Monday, 11/03/2003 12:59:33 PM

Monday, November 03, 2003 12:59:33 PM

Post# of 252498
Combretastatin is on my watch list, but I am more concerned about Macugen and Lucentis. So let me turn this around and ask why you find Combretastatin such a compelling threat; i.e. why do you think it will be either safer or more effective than other anti-angio drug candidates?

BTW: if there is ever a head-to-head trial of Squalamine vs Combretastatin, the trial will be known as “Shark vs Bark.”


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.